PowerTap Hydrogen Capital Corp has issued an update on its 49%-owned Progressus Clean Technologies Inc subsidiary, noting that the company executed a Letter of Intent (LOI) in June to be acquired by BioQuest Corp. BioQuest will acquire all issued and outstanding shares of Progressus, and Progressus shareholders will receive BioQuest shares. More details from the transaction will be released once the definitive agreement is executed, the company said.
MySize Inc said it has struck a deal with a Brazilian-based clothing brand, which will see it license the company's MySizeID mobile app sizing solution. The solution, which will allow customers to find the perfect fit, is expected to go live for 7 For All Mankind (Brazil) customers in the third quarter of 2022. "We are excited to work with a leading brand in Brazil that serves high-end savvy customers within the denim-fashion field," said Ronen Luzon, CEO and founder of MySize in a statement. "7 For All Mankind's commitment to continuous improvement to serve humanity is admirable, and MySizeID is pleased to partner with them in their mission."
Todos Medical Ltd has said that its majority-owned joint venture 3CL Pharma Ltd has once again highlighted the case for its oral dietary supplement Tollovid, pointing to a pre-print in ResearchGate of a study that used the product. The study, entitled 'Tollovid as a Rescue Agent for Paxlovid Rebound in Acute COVID-19', outlined the case, overseen by Dr Lee Morgentaler in concert with Andrew A. Blumenthal, RN ADS, of a patient with Post-Acute Sequelae of COVID (PASC, or Long COVID) who experienced multiple reinfections with SARS-CoV-2 virus over 27 months. The patient experienced full COVID symptom resolution with a 5-day course of Paxlovid treatment following positive PCR after which the patient immediately experienced a COVID rebound that was resolved following consumption of supplementation with 3CL protease inhibitor immune support dietary supplement Tollovid, the study showed.
Analysts at Noble Capital Corp reiterated an 'Outperform' rating and US$3.10 price target for Cypress Development Corp after the firm hosted Cypress management for a series of well-attended investor meetings in Kansas City and St Louis. In a note to clients, the analysts highlighted the fact that lithium extraction recently began at the company's pilot plant with acid leaching a slurry of lithium-bearing claystone, and extractions of lithium in leaching are running between 83% and 85%.
Braxia Scientific Corp has reported a near 50% increase in revenue in its fiscal year to end-March 2022 as it looks to "significantly" scale its offerings across North America. The medical research company, which provides ketamine treatments for depression and related disorders, said revenue came in at C$1.49 million for fiscal 2022 compared to revenue of C$1.008 million in the year to March 31, 2021, an increase of 47.5% year-on-year. The company also significantly narrowed its net loss, which was C$12.1 million for fiscal 2022 compared to a net loss of C$88.8 million for fiscal 2021. "We have established Braxia as a trusted and advanced clinic group and research platform," said Dr Roger McIntyre, the CEO of Braxia in a statement.
Vejii Holdings Ltd has announced that, in light of current market conditions and the cash needs of the company, its board of directors has approved management to initiate a process to identify, examine and pursue strategic alternatives to its current business. Through the strategic review process, Vejii said, its management will focus on evaluating options which it believes are in the best interest of the company and in charting the most accretive path forward to maximize shareholder value. "I'm very proud of the business that we've built, and in light of the current market conditions, the Company's valuation and need for capital, we will be focused on identifying opportunities that are in the best interest of the Company and our shareholders.", said Kory Zelickson, CEO of Vejii in a statement.
Xeris Biopharma Holdings Inc has noted that Tetris Pharma - its commercialization partner for Ogluo in the UK, EEA, and Switzerland - is to be acquired by Arecor Therapeutics PLC, a UK-based, publicly traded, globally focused biopharmaceutical company. Contingent upon a successful capital offering by Arecor, under the terms of the proposed acquisition, the UK-based company has agreed to acquire Tetris Pharma and will continue to commercialize Ogluo in the UK and EEA. "We look forward to working with Arecor as our commercial partner if the proposed acquisition is completed. Arecor is a diversified and well-capitalized company with a key focus on the diabetes space. Having our ready-to-use glucagon, Ogluo, commercialized in the UK and EEA by Arecor would be a very positive step forward in our view," said Paul R. Edick, Xeris' chairman and CEO.
ImagineAR Inc has announced a three-year private label mobile app tie-up with London-based creative agency EngageWorks. ImagineAR and its platform ImagineAR.com allows businesses to instantly create their own mobile phone experiential augmented reality (AR) campaigns. "We are seeing the need for quality augmented experiences – joining physical and digital to get joined up and parallel experiences," Steve Blyth, CEO of EngageWorks, said in a statement. "ImagineAR reality tools provide new and creative ways to engage with customers. We believe that our partnership will create an exciting and new model to help maximize the customer experience in the retail, brand but also corporate sectors," he added.
American Resources Corporation announced that its majority-owned ReElement Technologies division has successfully produced greater than 99.5% pure isolated dysprosium, neodymium and praseodymium/neodymium rare earth elements (REEs) from its first commercial-scale rare earth and battery element isolation and purification facility in Indiana. Achieving ultra-high purity levels of these REEs comes from the facility’s first commercial run through its ligand-assisted displacement (LAD) chromatography production train, the company said. “We have stated from day one that not only would we be first in the US to commercially produce separated and ultra-high purity rare earth elements, but we would also do so in an economically viable process utilizing unprecedented environmentally-safe methods,” American Resources CEO Mark Jensen said in a statement. “Our initial production we believe showcases that chromatography, in the isolation and purification of rare earth and critical elements, when used at commercial scale actually produces better results than when in the lab.”
Tiziana Life Sciences Ltd has announced the presentation of a study entitled, 'Treatment of Alzheimer's disease by modulation of microglial neuroinflammation by nasal anti-CD3 mAb' at the Alzheimer's Association International Conference (AAIC). The company said that in the study animal models of Alzheimer's disease (AD) demonstrated that microglia activity was restored and cognition was improved following the dosing of intranasal anti-CD3 monoclonal antibody. The study was presented virtually at the AAIC by Dr Howard L. Weiner, co-director of the Ann Romney Center for Neurologic Diseases at the Brigham and Women's Hospital (BWH) and chairman of Tiziana's Scientific Advisory Board on Sunday, July 31, 2022. Based on these results, Tiziana said it is evaluating conducting trials of nasal anti-CD3 (Foralumab) in patients with Alzheimer's disease.
Zoglo's Incredible Food Corp has announced that its chief executive officer, Anthony Morello, has retired. The company's chief operating officer, Jim Delsnyder, who has worked alongside of the CEO over the last 18 months will take over as the interim CEO and Morello will stay on as an adviser to the company until at least the end of 2022. Paul Del Duca, chairman of the board of directors of the company, commented: "We wish Tony all the best of health and happiness in his retirement and thank him for his immense contributions to the company's business. We are also extremely confident that Jim can step right in and we will not skip a beat."
GR Silver Mining Ltd announced that Michael Thomson has resigned as director of the company. Thomson had served as an independent director of GR Silver since 2018. GR Silver said its board of directors and management team would like to take this opportunity to thank him for his contributions during his time as director and wish him well in all his future endeavors.
Mountain Boy Minerals Ltd said it has closed the non-brokered private placement for non-flow-through units totalling $1 million, as announced on July 26. The placement involved a single private investor. Each unit, priced at 12 cents, will comprise one common share and one common share purchase warrant. Each warrant shall be exercisable to acquire one common share at a price of 12 cents per warrant share for a period of 24 months from the closing of the offering, expiring on July 29, 2024. All securities will be subject to a four-month hold period from the date of closing, expiring on November 30, 2022. The proceeds raised from the financing will be used for working capital and prioritized to the Telegraph project, where exploration is currently underway.
Tracesafe Inc has announced that, further to its news release dated July 12, 2022, it completed its acquisition of Offsety, a carbon offset marketplace, on July 21, 2022. Under the transaction, TraceSafe issued 2,000,000 common shares of the company, valued at C$270,000 on the date of closing, based on the 20-day volume weighted average price of such shares on the CSE as of the business day immediately preceding closing, being C$0.135.
Delota Corp has announced that further to its press release dated January 27, 2021, the outstanding secured loan, in the principal amount of $200,000 between the company and an independent third party, at the time the Loan was entered into, has been assigned to a corporation controlled by the company's chief executive officer, subject to TSX Venture Exchange approval. As of the date hereof, the outstanding amount owing by the company under the terms of the loan, inclusive of accrued interest, fees, expenses, including legal fees, and other amounts is $271,510, which amount continues to accrue at a nominal interest rate of 21.70% per annum. The loan bears interest at a nominal interest rate of 21.70% per annum, and is payable on demand. The company's obligations under the loan agreement, is guaranteed by its wholly-owned subsidiary, Spyder Cannabis Subco Inc and is secured solely by a first-raking security interest granted against certain specified assets and inventory of Spyder Subco, under, respectively, a guarantee agreement and a general security agreement executed by Spyder Subco in favour of the lender, as assigned. The security Interest ranks pari passu with the security interest granted by Spyder Subco to an existing lender of the company.
Plurilock Security Inc has announced that during its Annual General Meeting of shareholders held on July 29, 2022, each of the five nominees listed in Plurilock's management information circular dated June 13, 2022, were elected as directors. At the meeting, Plurilock's shareholders also voted in favor of the appointment of Plurilock's auditor, approved the company's Share Option Plan (SOP), and the adoption of the company's Employee Share Purchase Plan (ESPP), all as described in the circular. A total of 8,194,111 shares were represented at the meeting, representing 11.46% of the company's issued and outstanding common shares.
Zeb Nickel Corp said that at its recent annual general meeting of stockholders, held on July 25, 2022, the following proposals were duly ratified by the company's stockholders: Wayne Isaacs, Anton Drescher, Richard Montjoie, Tom Panoulias, Greg Mckenzie, Jay Vieira and John Zorbas were elected to the board of directors of the company; Smythe LLP chartered professional accounts were reappointed as the company's auditors for the ensuing year; and the company's rolling stock option plan was approved.
KULR Technology Group Inc has said it will hold a conference call on Monday, August 15, 2022, at 4.30pm Eastern time (1.30pm Pacific time) to discuss its financial results for the second quarter ended June 30, 2022, which will be issued in a press release prior to the call. KULR management will host the conference call, followed by a question-and-answer period. US dial-in: 855-459-0165; access code: 361411; webcast: https://www.webcaster4.com/Webcast/Page/2905/46303. The conference call will be broadcast live and available for replay here and via the investor relations section of the company's website.
Perma-Fix Environmental Services Inc has announced that it will host a conference call at 11.00am Eastern Time on Friday, August 5, 2022. The conference call will be led by Mark J. Duff, Perma-Fix chief executive officer, Dr Louis F. Centofanti, executive vice president of Strategic Initiatives, and Ben Naccarato, executive vice president and chief financial officer. The conference call will be available via telephone by dialing toll-free 877-545-0320 for US callers or +1 973-528-0002 for international callers, and by entering access code: 963791. A webcast of the call may be accessed at https://www.webcaster4.com/Webcast/Page/2243/46310. The webcast will also be archived on the company's website and a telephone replay of the call will be available approximately one hour following the call, through Friday, August 12, 2022, and can be accessed by dialing 877-481-4010 for US callers or +1 919-882-2331 for international callers and entering access code: 46310.